{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:21:24Z","timestamp":1791055284575,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00063-022-00908-6","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T16:45:48Z","timestamp":1647535548000},"page":"200-205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Herzfrequenzkontrolle im Schock","Heart rate control in shock"],"prefix":"10.1007","volume":"117","author":[{"given":"Henning","family":"Lemm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Buerke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,17]]},"reference":[{"key":"908_CR1","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/0895-7061(96)00203-8","volume":"9","author":"J Soma","year":"1996","unstructured":"Soma\u00a0J, Aakhus\u00a0S, Dahl\u00a0K, Sl\u00f8rdahl\u00a0S, Wiseth\u00a0R, Wider\u00f8e\u00a0TE (1996) Hemodynamics in white coat hypertension compared to ambulatory hypertension and normotension. Am J Hypertens 9:1090\u20131098","journal-title":"Am J Hypertens"},{"key":"908_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/00126097-200110000-00003","volume":"6","author":"SD Pierdomenico","year":"2001","unstructured":"Pierdomenico\u00a0SD, Bucci\u00a0A, Lapenna\u00a0D, Cuccurullo\u00a0F, Mezzetti\u00a0A (2001) Clinic and ambulatory heart rate in sustained and white-coat hypertension. Blood Press Monit 6:239\u2013244","journal-title":"Blood Press Monit"},{"key":"908_CR3","first-page":"65","volume":"29","author":"JR Halliwill","year":"2001","unstructured":"Halliwill\u00a0JR (2001) Mechanisms and clinical implications of post-exercise hypotension in humans. Exerc Sport Sci Rev 29:65\u201370","journal-title":"Exerc Sport Sci Rev"},{"key":"908_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2991\/artres.k.191210.001","volume":"25","author":"JL Izzo","year":"2019","unstructured":"Izzo\u00a0JL, Anwar\u00a0MA, Elango\u00a0K, Ahmed\u00a0R, Osmond\u00a0P (2019) Decoupling of heart rate and blood pressure: hemodynamic counter-regulatory mechanisms and their implications. Artery Res 25:87\u201394","journal-title":"Artery Res"},{"key":"908_CR5","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.chest.2018.03.040","volume":"154","author":"NA Bosch","year":"2018","unstructured":"Bosch\u00a0NA, Cimini\u00a0J, Walkey\u00a0AJ (2018) Atrial fibrillation in the ICU. Chest 154:1424\u20131434","journal-title":"Chest"},{"key":"908_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1001\/archsurg.1972.04180010040011","volume":"104","author":"JL Berk","year":"1972","unstructured":"Berk\u00a0JL, Hagen\u00a0JF, Maly\u00a0G, Koo\u00a0R (1972) The treatment of shock with beta adrenergic blockade. Arch Surg 104:46\u201351","journal-title":"Arch Surg"},{"key":"908_CR7","first-page":"165","volume":"38","author":"CR Benedict","year":"1992","unstructured":"Benedict\u00a0CR, Rose\u00a0JA (1992) Arterial norepinephrine changes in patients with septic shock. Circ Shock 38:165\u2013172","journal-title":"Circ Shock"},{"key":"908_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/01.CCM.0000150028.64264.14","volume":"33","author":"O Sander","year":"2005","unstructured":"Sander\u00a0O, Welters\u00a0ID, Fo\u00ebx\u00a0P, Sear\u00a0JW (2005) Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a\u00a0high risk of cardiac complications. Crit Care Med 33:81\u201388 (discussion 241\u2013242)","journal-title":"Crit Care Med"},{"key":"908_CR9","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1007\/s00134-012-2531-2","volume":"38","author":"CA Schmittinger","year":"2012","unstructured":"Schmittinger\u00a0CA, Torgersen\u00a0C, Luckner\u00a0G, Schr\u00f6der\u00a0DCH, Lorenz\u00a0I, D\u00fcnser\u00a0MW (2012) Adverse cardiac events during catecholamine vasopressor therapy: a\u00a0prospective observational study. Intensive Care Med 38:950\u2013958","journal-title":"Intensive Care Med"},{"key":"908_CR10","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jama.2013.278477","volume":"310","author":"A Morelli","year":"2013","unstructured":"Morelli\u00a0A, Ertmer\u00a0C, Westphal\u00a0M et\u00a0al (2013) Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA 310:1683\u20131691","journal-title":"JAMA"},{"key":"908_CR11","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/bja\/aex231","volume":"119","author":"C Fuchs","year":"2017","unstructured":"Fuchs\u00a0C, Wauschkuhn\u00a0S, Scheer\u00a0C, Vollmer\u00a0M, Meissner\u00a0K, Kuhn\u00a0S\u2011O, Hahnenkamp\u00a0K, Morelli\u00a0A, Gr\u00fcndling\u00a0M, Rehberg\u00a0S (2017) Continuing chronic beta-blockade in the acute phase of severe sepsis and septic shock is associated with decreased mortality rates up to 90\u00a0days. Br J Anaesth 119:616\u2013625","journal-title":"Br J Anaesth"},{"key":"908_CR12","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1055\/s-0028-1100944","volume":"133","author":"R Hennen","year":"2008","unstructured":"Hennen\u00a0R, Friedrich\u00a0I, Hoyer\u00a0D et\u00a0al (2008) Autonome Dysfunktion und Betablocker beim Multiorgandysfunktionssyndrom. Dtsch Med Wochenschr 133:2500\u20132504","journal-title":"Dtsch Med Wochenschr"},{"key":"908_CR13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1515\/BMT.2006.052","volume":"51","author":"H Schmidt","year":"2006","unstructured":"Schmidt\u00a0H, M\u00fcller-Werdan\u00a0U, Hoffmann\u00a0T et\u00a0al (2006) Attenuated autonomic function in multiple organ dysfunction syndrome across three age groups. Biomed Tech 51:264\u2013267","journal-title":"Biomed Tech"},{"key":"908_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jcrc.2013.12.015","volume":"29","author":"H Schmidt","year":"2014","unstructured":"Schmidt\u00a0H, Lotze\u00a0U, Ghanem\u00a0A et\u00a0al (2014) Relation of impaired interorgan communication and parasympathetic activity in chronic heart failure and multiple-organ dysfunction syndrome. J Crit Care 29:367\u2013373","journal-title":"J Crit Care"},{"key":"908_CR15","doi-asserted-by":"publisher","first-page":"A1","DOI":"10.1093\/eurheartj\/sux037","volume":"20","author":"H Domanovits","year":"2018","unstructured":"Domanovits\u00a0H, Wolzt\u00a0M, Stix\u00a0G (2018) Landiolol: pharmacology and its use for rate control in atrial fibrillation in an emergency setting. Eur Heart J Suppl 20:A1\u2013A3","journal-title":"Eur Heart J Suppl"},{"key":"908_CR16","doi-asserted-by":"publisher","first-page":"100571","DOI":"10.1016\/j.eclinm.2020.100571","volume":"28","author":"N Matsuda","year":"2020","unstructured":"Matsuda\u00a0N, Nishida\u00a0O, Taniguchi\u00a0T et al (2020) Impact of patient characteristics on the efficacy and safety of landiolol in patients with sepsis-related tachyarrhythmia: Subanalysis of the J\u2011Land 3S randomised controlled study. EClinicalMedicine 28:100571","journal-title":"EClinicalMedicine"},{"key":"908_CR17","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S2213-2600(20)30037-0","volume":"8","author":"Y Kakihana","year":"2020","unstructured":"Kakihana\u00a0Y, Nishida\u00a0O, Taniguchi\u00a0T, Okajima\u00a0M, Morimatsu\u00a0H, Ogura\u00a0H, Yamada\u00a0Y, Nagano\u00a0T, Morishima\u00a0E, Matsuda\u00a0N (2020) Efficacy and safety of landiolol, an ultra-short-acting \u03b21-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a\u00a0multicentre, open-label, randomised controlled trial. Lancet Respir Med 8:863\u2013872","journal-title":"Lancet Respir Med"},{"key":"908_CR18","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1016\/j.chest.2021.01.009","volume":"159","author":"D Hasegawa","year":"2021","unstructured":"Hasegawa\u00a0D, Sato\u00a0R, Prasitlumkum\u00a0N, Nishida\u00a0K, Takahashi\u00a0K, Yatabe\u00a0T, Nishida\u00a0O (2021) Effect of ultrashort-acting \u03b2\u2011blockers on mortality in patients with sepsis with persistent tachycardia despite initial resuscitation: a systematic review and meta-analysis of randomized controlled trials. Chest 159:2289\u20132300","journal-title":"Chest"},{"key":"908_CR19","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s40265-013-0077-4","volume":"73","author":"GL Plosker","year":"2013","unstructured":"Plosker\u00a0GL (2013) Landiolol: a review of its use in Intraoperative and postoperative tachyarrhythmias. Drugs 73:959\u2013977","journal-title":"Drugs"},{"key":"908_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13054-020-03445-w","volume":"25","author":"B Levy","year":"2021","unstructured":"Levy\u00a0B, Fritz\u00a0C, Piona\u00a0C, Duarte\u00a0K, Morelli\u00a0A, Guerci\u00a0P, Kimmoun\u00a0A, Girerd\u00a0N (2021) Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a\u00a0pilot study. Crit Care 25:21","journal-title":"Crit Care"},{"key":"908_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40560-021-00552-w","volume":"9","author":"D Hasegawa","year":"2021","unstructured":"Hasegawa\u00a0D, Sato\u00a0R, Nishida\u00a0O (2021) \u03b21-blocker in sepsis. j intensive care 9:39","journal-title":"j intensive care"},{"key":"908_CR22","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.chest.2020.10.049","volume":"159","author":"NA Bosch","year":"2021","unstructured":"Bosch\u00a0NA, Rucci\u00a0JM, Massaro\u00a0JM, Winter\u00a0MR, Quinn\u00a0EK, Chon\u00a0KH, McManus\u00a0DD, Walkey\u00a0AJ (2021) Comparative Effectiveness of Heart Rate Control Medications for the Treatment of Sepsis-Associated Atrial Fibrillation. Chest 159:1452\u20131459","journal-title":"Chest"},{"key":"908_CR23","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.recesp.2016.11.039","volume":"70","author":"PM Izco","year":"2017","unstructured":"Izco\u00a0PM, Castej\u00f3n\u00a0B, Piedras\u00a0MJ, Zamorano\u00a0JL, Sanmart\u00edn\u00a0M, Zaragoza\u00a0C (2017) Effects of Ivabradine on heart rate and Hemodynamic parameters in a\u00a0swine model of cardiogenic shock. Rev Esp Cardiol (Engl Ed) 70:1139\u20131141","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"908_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/SHK.0000000000000992","volume":"49","author":"S Nuding","year":"2018","unstructured":"Nuding\u00a0S, Schr\u00f6der\u00a0J, Presek\u00a0P, Wienke\u00a0A, M\u00fcller-Werdan\u00a0U, Ebelt\u00a0H, Werdan\u00a0K (2018) Reducing elevated heart rates in patients with multiple organ dysfunction syndrome with the if (funny channel current) inhibitor Ivabradine. Shock 49:402\u2013411","journal-title":"Shock"},{"key":"908_CR25","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s40261-016-0424-9","volume":"36","author":"F Barill\u00e0","year":"2016","unstructured":"Barill\u00e0\u00a0F, Pannarale\u00a0G, Torromeo\u00a0C et al (2016) Ivabradine in patients with ST-elevation myocardial infarction complicated by cardiogenic shock: a preliminary randomized prospective study. Clin Drug Investig 36:849\u2013856","journal-title":"Clin Drug Investig"},{"key":"908_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00101-020-00868-6","volume":"70","author":"K Werdan","year":"2021","unstructured":"Werdan\u00a0K, Boeken\u00a0U, Briegel\u00a0MJ et al (2021) Short version of the 2nd edition of the German-Austrian S3 guidelines \u201cCardiogenic shock complicating myocardial infarction-Diagnosis, monitoring and treatment\u201d. Anaesthesist 70:42\u201370","journal-title":"Anaesthesist"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-022-00908-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00063-022-00908-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-022-00908-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T14:34:50Z","timestamp":1649169290000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00063-022-00908-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,17]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["908"],"URL":"https:\/\/doi.org\/10.1007\/s00063-022-00908-6","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,17]]},"assertion":[{"value":"21 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"H.\u00a0Lemm und M.\u00a0Buerke geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}